Balyasny Asset Management
PRAH

Balyasny Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Balyasny Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-30,000
Closed -$2.25M – 2169
2017
Q2 		$2.25M Buy
+30,000
New +$2.08M 0.01% 908

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Balyasny Asset Management's PRAH Position: Q3 2021 in Review

Balyasny Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 100,680 shares — an estimated $16.6M sold.

Balyasny Asset Management first reported a position in PRAH in Q3 2016 and held it in 18 quarters. The position peaked at $35.2M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Balyasny Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 100,680 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $16.6M.
  • Balyasny Asset Management first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 18 quarters.
  • Balyasny Asset Management's PRA Health Sciences, Inc. position peaked at $35.2M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.